Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IDEAYA Biosciences, Inc. Logo
Clinical-stage oncology company developing targeted therapies using synthetic lethality.
United States of America
IDYA
Idorsia Ltd Logo
Biopharmaceutical company developing small-molecule medicines for multiple therapeutic areas.
Switzerland
IDIA
ILDONG HOLDINGS CO.,LTD  Logo
A holding company managing a diversified healthcare group in pharmaceuticals and bioscience.
South Korea
000230
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops, manufactures, and commercializes a broad range of healthcare products.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops and manufactures antibiotics, cardiovascular agents, and anesthetics.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops and manufactures a diverse range of pharmaceuticals and consumer health products.
South Korea
007570
I-Mab Logo
Global biotech company developing bispecific antibodies for immuno-oncology.
United States of America
IMAB
ImageneBio, Inc. Logo
Develops therapeutics for immunological, autoimmune, and inflammatory diseases.
United States of America
IMA
IMGT Corporation Limited Logo
Develops a drug delivery platform using focused ultrasound and nanotechnology.
South Korea
456570
Immatics N.V. Logo
Clinical-stage biopharma developing T cell receptor immunotherapies for cancer.
United States of America
IMTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.